Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI)
(2022) In European Radiology 32(6). p.4036-4045- Abstract
Abstract: Breast density is an independent risk factor for the development of breast cancer and also decreases the sensitivity of mammography for screening. Consequently, women with extremely dense breasts face an increased risk of late diagnosis of breast cancer. These women are, therefore, underserved with current mammographic screening programs. The results of recent studies reporting on contrast-enhanced breast MRI as a screening method in women with extremely dense breasts provide compelling evidence that this approach can enable an important reduction in breast cancer mortality for these women and is cost-effective. Because there is now a valid option to improve breast cancer screening, the European Society of Breast Imaging... (More)
Abstract: Breast density is an independent risk factor for the development of breast cancer and also decreases the sensitivity of mammography for screening. Consequently, women with extremely dense breasts face an increased risk of late diagnosis of breast cancer. These women are, therefore, underserved with current mammographic screening programs. The results of recent studies reporting on contrast-enhanced breast MRI as a screening method in women with extremely dense breasts provide compelling evidence that this approach can enable an important reduction in breast cancer mortality for these women and is cost-effective. Because there is now a valid option to improve breast cancer screening, the European Society of Breast Imaging (EUSOBI) recommends that women should be informed about their breast density. EUSOBI thus calls on all providers of mammography screening to share density information with the women being screened. In light of the available evidence, in women aged 50 to 70 years with extremely dense breasts, the EUSOBI now recommends offering screening breast MRI every 2 to 4 years. The EUSOBI acknowledges that it may currently not be possible to offer breast MRI immediately and everywhere and underscores that quality assurance procedures need to be established, but urges radiological societies and policymakers to act on this now. Since the wishes and values of individual women differ, in screening the principles of shared decision-making should be embraced. In particular, women should be counselled on the benefits and risks of mammography and MRI-based screening, so that they are capable of making an informed choice about their preferred screening method. Key Points: • The recommendations in Figure 1 summarize the key points of the manuscript
(Less)
- author
- author collaboration
- organization
- publishing date
- 2022
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Breast density, Decision-making, shared, Early detection of cancer, Magnetic resonance imaging, Mammography
- in
- European Radiology
- volume
- 32
- issue
- 6
- pages
- 4036 - 4045
- publisher
- Springer
- external identifiers
-
- pmid:35258677
- scopus:85126012571
- ISSN
- 0938-7994
- DOI
- 10.1007/s00330-022-08617-6
- language
- English
- LU publication?
- yes
- id
- df0da9c9-b217-4d75-85de-f61f5017d116
- date added to LUP
- 2022-04-22 15:45:40
- date last changed
- 2024-04-25 13:53:50
@article{df0da9c9-b217-4d75-85de-f61f5017d116,
abstract = {{<p>Abstract: Breast density is an independent risk factor for the development of breast cancer and also decreases the sensitivity of mammography for screening. Consequently, women with extremely dense breasts face an increased risk of late diagnosis of breast cancer. These women are, therefore, underserved with current mammographic screening programs. The results of recent studies reporting on contrast-enhanced breast MRI as a screening method in women with extremely dense breasts provide compelling evidence that this approach can enable an important reduction in breast cancer mortality for these women and is cost-effective. Because there is now a valid option to improve breast cancer screening, the European Society of Breast Imaging (EUSOBI) recommends that women should be informed about their breast density. EUSOBI thus calls on all providers of mammography screening to share density information with the women being screened. In light of the available evidence, in women aged 50 to 70 years with extremely dense breasts, the EUSOBI now recommends offering screening breast MRI every 2 to 4 years. The EUSOBI acknowledges that it may currently not be possible to offer breast MRI immediately and everywhere and underscores that quality assurance procedures need to be established, but urges radiological societies and policymakers to act on this now. Since the wishes and values of individual women differ, in screening the principles of shared decision-making should be embraced. In particular, women should be counselled on the benefits and risks of mammography and MRI-based screening, so that they are capable of making an informed choice about their preferred screening method. Key Points: • The recommendations in Figure 1 summarize the key points of the manuscript</p>}},
author = {{Mann, Ritse M. and Athanasiou, Alexandra and Baltzer, Pascal A.T. and Camps-Herrero, Julia and Clauser, Paola and Fallenberg, Eva M. and Forrai, Gabor and Fuchsjäger, Michael H. and Helbich, Thomas H. and Killburn-Toppin, Fleur and Lesaru, Mihai and Panizza, Pietro and Pediconi, Federica and Pijnappel, Ruud M. and Pinker, Katja and Sardanelli, Francesco and Sella, Tamar and Thomassin-Naggara, Isabelle and Zackrisson, Sophia and Gilbert, Fiona J. and Kuhl, Christiane K.}},
issn = {{0938-7994}},
keywords = {{Breast density; Decision-making, shared; Early detection of cancer; Magnetic resonance imaging; Mammography}},
language = {{eng}},
number = {{6}},
pages = {{4036--4045}},
publisher = {{Springer}},
series = {{European Radiology}},
title = {{Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI)}},
url = {{http://dx.doi.org/10.1007/s00330-022-08617-6}},
doi = {{10.1007/s00330-022-08617-6}},
volume = {{32}},
year = {{2022}},
}